R1

Before a TB Vaccine Exists, Africa Is Building the Route to People

MASH, a serious fatty liver disease, is becoming a cardiometabolic condition

Cervical Cancer Cannot Be Left Waiting at the Edge of the ADC Era

ESC Cardio-Oncology 2026: Cancer therapy is getting smarter. Cardiac protection is still playing catch-up.

Gastric Cancer Gets a New Biomarker Access Signal

Ebola Funding Finally Moves. The Virus Has Already Moved Faster.

Cardio-oncology demand is rising, but training gaps are holding systems back

Gastric Cancer Gets a New Biomarker Access Signal

Ebola Modelling Shows the Outbreak May Be Bigger Than the Count
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
